Luis Fernando Sanchez-Espino

Luis Fernando Sanchez-Espino

Auto-generated profile, based on publicly available information

Luis Fernando Sanchez-Espino

Division of Dermatology, Department of Pediatrics, Stollery Children's Hospital University of Alberta Edmonton Alberta Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in The Application of Clinical Genetics
Verified
Journal Article
Open access
PDF file
LSLuis Fernando Sánchez-Espino
Luis Fernando Sánchez-Espino
MIMarta Ivars
Marta Ivars
JAJAVIER ANTOÑANZAS
JAVIER ANTOÑANZAS
EBEulalia Baselga
Eulalia Baselga
Sturge-Weber syndrome (SWS) is a congenital, sporadic, and rare neurocutaneous disorder, characterized by the presence of a facial port-wine birthmark (PWB), glaucoma, and neurological manifestations including leptomeningeal angiomatosis and seizures. It is caused by a postzygotic, somatic, gain-of-function variant of the GNAQ gene, and more recently, the GNA11 gene in association with distinctive clinical features. Neuroimaging can help identify and stratify patients at risk for significant complications allowing closer follow-up; although no presymptomatic treatment has been demonstrated to be effective to date, these patients could benefit from early treatment and/or supportive interventions. Choroid plexus (CP) thickness measurements in brain magnetic resonance imaging (MRI) have a high sensitivity and specificity for early and incipient changes in SWS. In contrast, the absence of pathologic findings makes it possible to rule out associated neurological involvement and leads to periodical observation, with new imaging studies only in cases of new clinical signs/symptoms. Periodic ophthalmological examination is also recommended every 3 months during the first year and yearly afterwards to monitor for glaucoma and choroidal hemangiomas. Treatment for SWS depends on the extent and areas that are affected. These include laser surgery for PWB, anticonvulsants in the case of brain involvement, with either seizures or abnormal EEG, and medical treatment or surgery for glaucoma. Sirolimus has been used in a limited number of patients and appears to be a safe and potentially effective treatment for cutaneous and extra-cutaneous features, however controlled clinical studies have not been carried out. Better knowledge of GNAQ/GNA11 molecular pathways will help to develop future targeted treatments.

6 February 2019 in International Breastfeeding Journal
Verified
Journal Article
Open access
PDF file
LSLuis Fernando Sanchez-Espino
Luis Fernando Sanchez-Espino
GZGregorio Zuniga-Villaneuva
Gregorio Zuniga-Villaneuva
Jose Luis Ramirez-GarciaLunaJose Luis Ramirez-GarciaLuna
Jose Luis Ramirez-GarciaLuna
Early skin-to-skin contact promotes infant physiologic stability, provides warmth and makes breast milk readily available. Despite the known benefits of early skin-to-skin contact, this practice is not included within standard care in the Mexican public healthcare system. After birth, newborns are usually taken to an incubator in the nursery where they transition to extrauterine life and receive either dextrose 5% or infant formula for their first feed. The aim of this study was to assess if a dual educational intervention in a rural hospital in Mexico could modify current practice and accomplish early skin-to-skin contact and early breastfeeding. A two-step educational intervention was designed. The first step was to educate the labor and birthing staff of the hospital, and the second step was to educate all pregnant women with uncomplicated pregnancies at 36 weeks’ gestation. The educational intervention explored the benefits, implications and steps of early skin-to-skin contact and early breastfeeding. All births were registered for the three month period following the intervention. The time of onset of skin-to-skin (SSC) contact, its duration and time of initiation of breastfeeding were recorded and analyzed using ANOVA testing. A total of 142 births met our inclusion criteria, from those, 77% (n = 109) received skin-to-skin contact and early breastfeeding. The average time of initiation of skin-to-skin contact in the first and last month of the study was 18.5 (± 2.2) and 9.6 (± 2.2) minutes of life, respectively (p < 0.001). The average duration of SSC in the first and last month was 22 (± 10.9) and 40.9 (± 17.4) minutes, respectively (p < 0.001). The average time of onset of breastfeeding in the first and last month was 48.9 (± 15) and 34.4 (± 16.7) minutes of life, respectively (p < 0.001). A simple and low-cost educational intervention achieved the inclusion of skin-to-skin contact and early breastfeeding as part of standard care in a rural hospital. Further studies could replicate our intervention in similar settings to test the generalizability of the findings.

16 May 2024 in American Journal of Clinical Dermatology
Verified
Journal Article
Closed access
PDF file
NCNicole Cherepacha
Nicole Cherepacha
FGFrances St George-Hyslop
Frances St George-Hyslop
BCBindiya Chugani
Bindiya Chugani
YAYousef Alabdeen
Yousef Alabdeen
LSLuis F. Sanchez-Espino
Luis F. Sanchez-Espino
RVRuud H.J. Verstegen
Ruud H.J. Verstegen

7 January 2024 in Arthritis Care & Research
Verified
Journal Article
Open access
LSLuis F. Sanchez‐Espino
Luis F. Sanchez‐Espino
NLNadia Luca
Nadia Luca
EPElena Pope
Elena Pope
RLRonald M. Laxer
Ronald M. Laxer
AKAndrea M. Knight
Andrea M. Knight
CSCathryn Sibbald
Cathryn Sibbald
Objective: The prevalence and types of psychosocial complications of juvenile localized scleroderma (JLS), also known as morphea, an inflammatory and sclerosing disease involving the skin, fascia, muscle, and bone, are poorly understood.Methods: We performed a systematic review of literature published between 2000 and 2020 in PubMed, EMBASE, the Cochrane Skin Group Specialized Register, the Cochrane Central Register of Controlled Trials, and the Cumulative Index to Nursing and Allied Health Literature using the search terms “scleroderma, localized,” “Morphea,” “anxiety,” “depression,” “resilience,” “social stigma,” “quality of life,” “mood,” or “stress” and limited the search to pediatric patients and English language. Patient demographics, characteristics of JLS, and comorbidities were extracted. The outcomes included measures of health‐related quality of life (HRQoL), psychosocial functioning, evaluation of self‐perception, and the treatment burden of the study population. The protocol was registered with PROSPERO (CRD42021257124). Thematic synthesis generated descriptive analysis.Results: Thirteen studies fulfilled the inclusion criteria: three retrospective cohort studies, two prospective cohort studies, and eight cross‐sectional studies. A total of 690 pediatric patients with JLS were included (n = 484 with linear scleroderma). Six studies used the Children's Dermatology Life Quality Index, reporting little to no effect on HRQoL. One study used the Health‐Related Quality of Life in Children and Adolescents Questionnaire and did not find differences between children with JLS or atopic dermatitis and healthy controls. One study used a self‐perception questionnaire that showed normal self‐worth of patients with JLS. Two studies used focus groups, both reporting elevated levels of stress, decreased self‐worth, “feeling different,” and bullying/teasing in patients with JLS. These emotions were associated with skin symptoms (pain, itch, and tightness), physical limitations, and treatment burden.Conclusion: Overall, quantitative studies did not report a statistically significant impairment in HRQoL in JLS. However, qualitative studies (focus groups) reported significant psychosocial impacts related to JLS. There is a need to develop a JLS‐specific tool for the HRQoL evaluation of this population.

20 October 2023 in Pediatric Dermatology
Verified
Journal Article
Closed access
LSLuis Fernando Sanchez‐Espino
Luis Fernando Sanchez‐Espino
CSCathryn Sibbald
Cathryn Sibbald
JSJennifer Stimec
Jennifer Stimec
RLRonald M. Laxer
Ronald M. Laxer
EPElena Pope
Elena Pope

31 March 2024 in Pediatric Dermatology
Verified
Journal Article
Open access
LSLuis Fernando Sánchez‐Espino
Luis Fernando Sánchez‐Espino
MIMarta Ivars
Marta Ivars
CTCarolina Prat Torres
Carolina Prat Torres
CLCinzia E. Lavarino
Cinzia E. Lavarino
NONagore Gené Olaciregui
Nagore Gené Olaciregui
EBEulàlia Baselga
Eulàlia Baselga
We report two cases with localized vascular malformations clinically resembling the “dominant lesion” seen in capillary malformation‐arteriovenous malformation (CM‐AVM) syndrome, however, lacking germline RASA1 variants but presenting double somatic RASA1 variants in affected tissue. Both patients presented with localized and superficial high‐flow vascular malformations were treated with surgery and laser therapy and showed partial resolution. The study underscores the rarity of somatic RASA1 variants, contributes to understanding the “second‐hit” pathophysiology in vascular lesions, and emphasizes the significance of clinical distinctions and genotyping for accurate diagnoses, offering implications for diagnosis, prognosis, and genetic counseling.